Cargando…
Antithrombotic Therapy after Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk. TAVR carries a risk for thrombotic and bleeding events, focusing on the importance of defining the opti...
Autores principales: | Mousa, Tariq A. M., Mahfouz, Ahmed, Mohammed, Nazar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231539/ https://www.ncbi.nlm.nih.gov/pubmed/35757447 http://dx.doi.org/10.4103/heartviews.heartviews_36_22 |
Ejemplares similares
-
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: An Overview
por: Hindi, Mathew N., et al.
Publicado: (2022) -
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement
por: Granger, Camille, et al.
Publicado: (2022) -
Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019) -
Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation
por: Zeng, Qingchun, et al.
Publicado: (2020) -
Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement
por: Han, Yaling
Publicado: (2022)